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LETTER TO THE EDITOR
doi:10.1002/ejhf.1324
What is the added value of
the waist-to-hip ratio on top
of the BIOSTAT risk
prediction model in patients
with heart failure? Reply
We thank Dr. Cao for his interest in our
paper. Dr. Cao addresses an important
topic regarding the study design of the
BIOSTAT-CHF study. Almost all patients
included were Caucasian patients, and to
conclude that the same association of waist-
to-hip ratio (WHR) with mortality exists in
other ethnicities, further studies should be
performed.1
The second question raised by Dr. Cao is
the additive value of WHR on top of the risk
prediction model within BIOSTAT-CHF.2 The
prediction models were developed to assess
the strongest predictors for mortality and/or
heart failure hospitalization. The predictors
in BIOSTAT-CHF for mortality were age,
blood urea nitrogen, N-terminal pro-B-type
natriuretic peptide, haemoglobin and use of ..
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.. beta-blocker. In our multivariable model, we
aimed to assess the independent association
of WHR with all-cause mortality within male
and female patients with heart failure, and
therefore corrected for all confounders. The
BIOSTAT-CHF prediction model contains
the strongest predictors for mortality, and
were also confounders in our manuscript.
Therefore we included these variables in
our multivariable Cox regression models,
together with other confounders. We found
that WHR was independently associated with
all-cause mortality in female patients with
heart failure.3 The additive value of WHR on
the risk prediction model is therefore not
the aim of our manuscript, we merely aimed
to investigate the independent association of
WHR with all-cause mortality, and therefore
corrected for the previously published risk
prediction model.
The last question raised by Dr. Cao
regards the association of adiposity and pro-
inflammatory cytokines such as C-reactive
protein. Unfortunately there are no avail-
able C-reactive protein measurements in
our cohort. However, we found a strong
association with a panel of inflammatory
markers, especially in female heart failure
patients. ..
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